TY  - RPRT
TI  - Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment.
AU  - Tracy B Bramlette
AU  - David H Lawson
AU  - Carl V Washington
AU  - Emir Veledar
AU  - Barry R Johns
AU  - Stacey F Brisman
AU  - Liana Abramova
AU  - Suephy C Chen
PY  - 2007
DO  - 10.1111/j.1524-4725.2007.33001.x
UR  - https://pubmed.ncbi.nlm.nih.gov/17214673/
ID  - 17214673
ER  -